MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...

Coffee is the fuel of many people's morning commutes, workouts, and late-night work sessions, but a new study suggests that ...

A Cedars-Sinai study helps explain why half of diabetes patients experience deterioration of the cornea, the transparent dome ...

Virtual reality (VR) gaming has gained significant attention in recent years, with an increasing number of users integrating ...

MeiraGTx is cashing in on a gene therapy that restored vision to 11 children who were born legally blind, licensing the ...

AI-driven oculomics is transforming eye scans into powerful tools for detecting heart, brain, and metabolic health risks ...

Trattler: Patients with severe dry eye can in some cases be exceptionally challenging, and it can feel as if therapies are ...

The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions.

The partnership grants Lilly worldwide exclusive rights to MeiraGTx’s AAV-AIPL1 program for treating Leber congenital ...

AI-powered retinal imaging closes healthcare gaps, enables earlier intervention, and reveals new insights into systemic ...

Scientists have found that they may be able to use the retina's blood vessels to help predict a person's heart disease risk ...

AI can make ophthalmology more accessible, accurate, and preventative by using smart optical technology and data-driven diagnostics.